Metastatic colorectal cancer: current state and future directions von Fakih, Marwan G

Volltext

Treatment of Metastatic Colorectal Cancer: ASCO Guideline von Morris, Van K, Kennedy, Erin B, Baxter, Nancy N, Benson, 3rd, Al B, Cercek, Andrea, Cho, May, Ciombor, Kristen K, Cremolini, Chiara, Davis, Anjee, Deming, Dustin A, Fakih, Marwan G, Gholami, Sepideh, Hong, Theodore S, Jaiyesimi, Ishmael, Klute, Kelsey, Lieu, Christopher, Sanoff, Hanna, Strickler, John H, White, Sarah, Willis, Jason A, Eng, Cathy

Volltext

Targeting KRAS in Colorectal Cancer von Wang, Chongkai, Fakih, Marwan

Volltext

Trastuzumab Plus Pertuzumab Resistance Does Not Preclude Response to Lapatinib Plus Trastuzumab in HER2‐Amplified Colorectal Cancer von Fakih, Marwan G.

Volltext

Systemic treatment for metastatic colorectal cancer in the era of precision medicine von Sandhu, Jaideep, Lavingia, Viraj, Fakih, Marwan

Volltext

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity von Canon, Jude, Rex, Karen, Saiki, Anne Y., Mohr, Christopher, Cooke, Keegan, Bagal, Dhanashri, Gaida, Kevin, Holt, Tyler, Knutson, Charles G., Koppada, Neelima, Lanman, Brian A., Werner, Jonathan, Rapaport, Aaron S., San Miguel, Tisha, Ortiz, Roberto, Osgood, Tao, Sun, Ji-Rong, Zhu, Xiaochun, McCarter, John D., Volak, Laurie P., Houk, Brett E., Fakih, Marwan G., O’Neil, Bert H., Price, Timothy J., Falchook, Gerald S., Desai, Jayesh, Kuo, James, Govindan, Ramaswamy, Hong, David S., Ouyang, Wenjun, Henary, Haby, Arvedson, Tara, Cee, Victor J., Lipford, J. Russell

Volltext

Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C von Fakih, Marwan G, Salvatore, Lisa, Esaki, Taito, Modest, Dominik P, Lopez-Bravo, David P, Taieb, Julien, Karamouzis, Michalis V, Ruiz-Garcia, Erika, Kim, Tae-Won, Kuboki, Yasutoshi, Meriggi, Fausto, Cunningham, David, Yeh, Kun-Huei, Chan, Emily, Chao, Joseph, Saportas, Yaneth, Tran, Qui, Cremolini, Chiara, Pietrantonio, Filippo

Volltext

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study von Meric-Bernstam, Funda, Hurwitz, Herbert, Raghav, Kanwal Pratap Singh, McWilliams, Robert R, Fakih, Marwan, VanderWalde, Ari, Swanton, Charles, Kurzrock, Razelle, Burris, Howard, Sweeney, Christopher, Bose, Ron, Spigel, David R, Beattie, Mary S, Blotner, Steven, Stone, Alyssa, Schulze, Katja, Cuchelkar, Vaikunth, Hainsworth, John

Volltext

SUMOylation of E2F1 Regulates Expression of EZH2 von Du, Li, Fakih, Marwan G, Rosen, Steven T, Chen, Yuan

Volltext

Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review von Shitara, Kohei, Falcone, Alfred, Fakih, Marwan G, George, Ben, Sundar, Raghav, Ranjan, Sandip, Van Cutsem, Eric

Volltext

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study von Strosberg, Jonathan, Mizuno, Nobumasa, Doi, Toshihiko, Grande, Enrique, Delord, Jean-Pierre, Shapira-Frommer, Ronnie, Bergsland, Emily, Shah, Manisha, Fakih, Marwan, Takahashi, Shunji, Piha-Paul, Sarina A, O'Neil, Bert, Thomas, Sajeve, Lolkema, Martijn P, Chen, Menghui, Ibrahim, Nageatte, Norwood, Kevin, Hadoux, Julien

Volltext

Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic von O'Leary, Michael P, Choong, Kevin C, Thornblade, Lucas W, Fakih, Marwan G, Fong, Yuman, Kaiser, Andreas M

Volltext

Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3 von Ross, Jeffrey S., Fakih, Marwan, Ali, Siraj M., Elvin, Julia A., Schrock, Alexa B., Suh, James, Vergilio, Jo‐Anne, Ramkissoon, Shakti, Severson, Eric, Daniel, Sugganth, Fabrizio, David, Frampton, Garrett, Sun, James, Miller, Vincent A., Stephens, Philip J., Gay, Laurie M.

Volltext

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer von Yoshino, Takayuki, Di Bartolomeo, Maria, Raghav, Kanwal, Masuishi, Toshiki, Loupakis, Fotios, Kawakami, Hisato, Yamaguchi, Kensei, Nishina, Tomohiro, Wainberg, Zev, Elez, Elena, Rodriguez, Javier, Fakih, Marwan, Ciardiello, Fortunato, Saxena, Kapil, Kobayashi, Kojiro, Bako, Emarjola, Okuda, Yasuyuki, Meinhardt, Gerold, Grothey, Axel, Siena, Salvatore

Volltext

Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic von O’Leary, Michael P., Choong, Kevin C., Thornblade, Lucas W., Fakih, Marwan G., Fong, Yuman, Kaiser, Andreas M.

Volltext

Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience von Gong, Jun, Cho, May, Sy, Marvin, Salgia, Ravi, Fakih, Marwan

Volltext

Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity von Ma, Wen Wee, Saif, Muhammad Wasif, El‐Rayes, Bassel F., Fakih, Marwan G., Cartwright, Thomas H., Posey, James A., King, Thomas R., von Borstel, Reid W., Bamat, Michael K.

Volltext

Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy von Cao, Xu, Chen, Jing, Li, Bolei, Dang, Jessica, Zhang, Wencan, Zhong, Xiancai, Wang, Chongkai, Raoof, Mustafa, Sun, Zuoming, Yu, Jianhua, Fakih, Marwan G, Feng, Mingye

Volltext

Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal von Du, Li, Li, Yi-Jia, Fakih, Marwan, Wiatrek, Rebecca L., Duldulao, Marjun, Chen, Zhenbin, Chu, Peiguo, Garcia-Aguilar, Julio, Chen, Yuan

Volltext

Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS) von Shitara, Kohei, George, Ben, Taieb, Julien, Sundar, Raghav, Fakih, Marwan G., Makris, Lukas, Benhadji, Karim A., Ghidini, Michele

Volltext